Having established that PIEZO1 is a primary actuator responsible for NLGN3-mediated shedding of CSPG4, we hypothesized that blocking the PIEZO1 response in glioma would mimic loss of microenvironmental NLGN3 and affect glioma growth in vivo2,3. This evidence concerns the gene NLGN3 and central nervous system cancer.